Search results
Biophytis Announces Transfer of ADSs to OTC Market
Digital Journal· 6 hours agoAnnounces Fiscal Second Quarter and Fiscal First Half 2024 Financial Results More from Digital...
Ipsen, Skyhawk to develop RNA-targeting pills for rare brain diseases
BioPharma Dive via Yahoo Finance· 3 days agoNonetheless, several have drawn the interest of large pharmaceutical companies. Ipsen, for instance,...
Tiger Aesthetics Medical, LLC Acquires Assets of Sientra, Inc.
Digital Journal· 6 hours agoVienna ball season back in full swing ‘Avatar 2’ success proves cinema in post-pandemic ‘resurgence’: Cameron North of ...
Coffee Memorial Blood Center seeks platelet donations amid low supply
KAMR Amarillo· 1 day agoOfficials with the Coffee Memorial Blood Center asked community members to donate blood platelets...
I left my daughter's dad 4 years ago and have zero interest in reentering the dating world
INSIDER via Yahoo News· 3 days agoWhen she was six months old, I asked him to leave. During those tough months, doctors diagnosed my...
Promising Treatment Approach for Aggressive Leukemia Identified
Technology Networks· 6 days agoScientists have uncovered a promising treatment strategy for an aggressive type of leukaemia –...
MD Anderson Research Highlights for April 24, 2024
Newswise· 23 hours agoThe University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These adva
Review explores cutaneous manifestations of myelodysplastic syndrome
Medical Xpress· 2 days agoCutaneous manifestations of myelodysplastic syndrome (MDS) are described in a perspective piece...
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against bluebird bio,...
Morningstar· 11 hours agoPomerantz LLP announces that a class action lawsuit has been filed against bluebird bio, Inc. (“bluebird” or the “Company”) (NASDAQ: BLUE). Such investors are advised to contact Danielle Peyton ...
Ex Vivo Drug Screening Identifies Personalized Treatments for Most Pediatric Cancer Patients in...
GenomeWeb News· 5 days agoA prospective study of First Ascent Biomedical's ex vivo drug screening platform plus genomic profiling has demonstrated the feasibility of the functional precision medicine approach to guide ...